Lobbying Effort Unites Congress Behind School Allergy Drive
This article is for subscribers only.
A lobbying effort by drugmaker Mylan Inc. and others for schools to stock products that treat severe allergic reactions, like the company’s popular EpiPen, has accomplished something rare in Washington: uniting Congress.
White House officials said President Barack Obama will sign the bill, cleared by the Senate last week, which encourages states to have schools buy and store the life-saving allergy drugs.